| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.00086 | 1 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.00094 | 1 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.00096 | 1 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.00097 | 1 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.00081 | 1 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.00066 | 1 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.00095 | 1 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.00078 | 1 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00044 | 1 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.00061 | 1 |